Webb John G, Dvir Danny
St Paul's Hospital, University of British Columbia, Vancouver, Canada.
Catheter Cardiovasc Interv. 2016 Feb 15;87(3):549-50. doi: 10.1002/ccd.26453.
Transcatheter treatment of calcific mitral valve disease with commercially available balloon-expandable valves is feasible Current clinical outcomes are suboptimal, consequently this should be considered only in severely symptomatic patients without other options Purpose-specific mitral valves may allow for this therapy to achieve its full potential.
